David Zaccardelli | President and Chief Executive Officer |
Mark Hahn | Chief Financial Officer |
Kathleen Rickard | Chief Medical Officer |
Christopher Martin | Senior Vice President Commercial |
Andreas Argyrides | Wedbush |
David Risinger | SVB Securities |
Thomas Shrader | BTIG |
Boobalan Pachaiyappan | H.C. Wainwright |
Joon Lee | Truist Securities |
Good morning. Welcome to Verona Pharma's First Quarter 2023 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a mode. Earlier this morning, Verona Pharma issued a press release announcing its financial results for the 3 months ended March 31, 2023. A copy can be found in the Investor Relations tab on the corporate website, www.veronapharma.com.